Pharmacological treatments for chronic non-malignant pain

International Review of Psychiatry

Volumn 12, Issue 2, 2000, Pages 148-156

  Clark, Michael R ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CLOMIPRAMINE; CLONAZEPAM; DESIPRAMINE; DOXEPIN; FLUOXETINE; GABAPENTIN; LAMOTRIGINE; MEXILETINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; MORPHINE; NEFAZODONE; NORTRIPTYLINE; OPIATE; OXYCODONE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; TOPIRIMATE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VALPROIC ACID; VENLAFAXINE; VERAPAMIL;

ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; CHRONIC PAIN; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DEPENDENCE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MIGRAINE; NAUSEA; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREMOR; URINE RETENTION; VERTIGO; VOMITING;

EID: 0034117503     PISSN: 09540261     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540260050007453     Document Type: Review

References (130)

1. ACUTE PAIN MANAGEMENT GUIDELINE PANEL (1992). Acute Pain Management: Operative or Medical Procedures and Trauma. Clinical Practice Guideline. AHCPR Pub. No. 92-0032. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services.
2. ADELMAN, J.U. & VON SEGGERN, R. (1995). Cost considerations in headache treatment. Part 1: Prophylactic migraine treatment. Headache, 35, 479-487.
3. AMERICAN GERIATRIC SOCIETY PANEL ON CHRONIC PAIN IN OLDER PERSONS (1998). The management of chronic pain in older persons. Journal of the American Geriatric Society, 46, 635-651.
4. ANTKIEWICZ-MICHALUK, L., ROMANSKA, I., MICHALUK, J. & VETULANI, J. (1991). Role of calcium channels in effects of antidepressant drugs on responsiveness to pain. Psychopharmacology, 105, 269-274.
5. ARKINSTALL, W., SANDLER, A., GOUGHNOUR, B., BABUL, N., HARSANYI, Z. & DARKE, A.C. (1995). Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial. Pain, 62, 169-178.
6. ATKINSON, J.H., SLATER, M.A., WILLIAMS, R.A., et al. (1998). A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain, 76, 287-296.
7. AYAJIKI, K., OKAMURA, T. & TODA, N. (1997). Flunarizine, an anti-migraine agent, impairs nitroxidergic nerve function in cerebral arteries. European Journal of Pharmacology, 329, 49-53.
8. BACKONJA, M., BEYDOUN, A., EDWARDS, K.R., et al. (1998). For the Gabapentin Diabetic Neuropathy Study Group. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. Journal of the American Medical Association, 280, 1831-1836.
9. BANK, J. (1994). A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis. Headache, 34, 476-478.
10. BARTUSCH, S.L., SANDERS, B.J., D'ALESSIO, J.G., et al. (1996). Clonazepam for the treatment of lancinating phantom limb pain. Clinical Journal of Pain, 12, 59-62.
11. 2+ and 5-HT antagonist dotarizine and other 5-HT receptor agonists and antagonists. Acta Physiology Pharmacology Bulgaria, 21, 93-98.
12. BENDTSEN, L., JENSEN, R. & OLESEN, J. (1996). A non-selective (amitriptyline), but not a selective (citalopram) serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. Journal of Neurology, Neurosurgery, and Psychiatry, 61, 285-290.
13. BERGOUIGNAN, M. (1942). Cures heureuses de nevralgies faciaales essentielles par le diphenyl-hydantoinate de soude. Reviews in Laryngology, Otology, and Rhinology, 63, 34-41.
14. BIANCHI, M., ROSSONI, G., SACERDOTE, P., et al. (1995). Carbamazepine exerts anti-inflammatory effects in the rat. European Journal Pharmacology, 294, 71-74.
15. BOULTON, A.J. (1993). Causes of neuropathic pain. Diabetes Medicine, 10(Suppl. 2), 87S-88S.
16. BOWERSOX, S.S., GADBOIS, T., SINGH, T., et al. (1996). Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. Journal of Pharmacology and Experimental Therapy, 279, 1243-1249.
17. BROSE, W.G., GUTLOVE, D.P., LUTHER, R.R., et al. (1997). Use of intrathecal SNX-111, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion pain. Clinical Journal of Pain, 13, 256-259.
18. BRYSON, H.M. & WILDE, M.I. (1996). Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states. Drugs and Aging, 8, 459-476.
19. CAMPBELL, R.W.F. (1987). Mexiletine. New England Journal of Medicine, 316, 29-34.
20. CANAVERO, S. & BONICALZI, V. (1996). Lamotrigine control of central pain. Pain, 68, 179-181.
21. CANCER PAIN MANAGEMENT GUIDELINE PANEL (1994). Management of Cancer Pain. Clinical Practice Guideline. AHCPR Pub. No. 94-0592. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services.
22. CHABAL, C., JACOBSON, L., CHANEY, E.F., MARIANO, A.J. (1992a). Narcotics for chronic pain: yes or no? A useless dichotomy. American Pain Society Journal, 1, 276-281.
23. CHABAL, C., JACOBSON, L., MARIANO, A.J., CHANEY, E.F. & BRITELL, C.W. (1992b).The use of oral mexiletine for the treatment of pain after peripheral nerve injury. Anesthesiology, 76, 513-517.
24. CHAPMAN, V., SUZUKI, R., CHAMARETTE, H.L.C., et al. (1998). Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain, 75, 261-272.
25. CHEUNG, H., KAMP, D. & HARRIS, E. (1992). An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Research, 13, 107-112.
26. COHEN, G.L. (1997). Protriptyline, chronic tension-type headaches, and weight loss in women. Headache, 37, 433-436.
27. CUTRER, F.M. & MOSKOWITZ, M.A. (1996). Wolff Avard 1996. The actions of valproate and neurosteroids in a model of trigeminal pain. Headache, 36, 579-585.
28. CUTRER, F.M., LIMMROTH, V. & MOSKOWITZ, M.A. (1997). Possible mechanisms of valproate in migraine prophylaxis. Cephalalgia, 17, 93-100.
29. DAVIS, R.W. (1993). Successful treatment for phantom pain. Orthopaedics, 16, 691-695.
30. DEJGARD, A., PETERSEN, P. & KASTRUP, J. (1988). Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet, 1, 9-11.
31. DELLEMIJN, P.L. & FIELDS, H.L. (1994). Do benzodiazepines have a role in chronic pain management? Pain, 57, 137-152.
32. DELLEMIJN, P.L. & VANNESTE, J.A. (1997). Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet, 349, 753-758.
33. DONNER, B., ZENZ, M.,TRYBA, M., et al. (1996). Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain, 64, 527-534.
34. FIELD, M.J., HOLLOMAN, E.F., MCCLEARY, S., et al. (1997). Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain. Journal of Pharmacology and Experimental Therapy, 282, 1242-1246.
35. FORMAN, W.B. (1996). Opioid analgesic drugs in the elderly. Clinics of Geriatric Medicine, 12, 489-500.
36. FOSTER, C.A. & BAFALOUKOS, J. (1994). Paroxetine in the treatment of chronic daily headache. Headache, 34, 587-589.
37. FRANCE, R.D. & KIRSHMAN, K.R. (1988). Psychotropic drugs in chronic pain. In: R.D. FRANCE & K.R. KIRSHMAN (Eds), Chronic pain. Washington, DC: American Psychiatric Association.
38. GALER, B.S. (1995). Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology, 45, S17-S25.
39. GALER, B.S., HARLE, J. & ROWBOTHAM, M.C. (1996). Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study. Journal of Pain and Symptom Management, 12, 161-167.
40. GANAPATHY, S., HERRICK, I.A., GELB, A.W., et al. (1997). Propofol patient-controlled sedation during hip or knee arthroplasty in elderly patients. Canadian Journal of Anaesthesia, 44, 385-389.
41. GATCH, M.B., NEGUS, S.S. & MELLO, N.K. (1998). Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys. Psychopharmacology, 135, 99-106.
42. GEAR, R.W., MIASKOWSKI, C., HELLER, P.H., et al. (1997). Benzodiazepine mediated antagonism of opioid analgesia. Pain, 71, 25-29.
43. GOODKIN, K., VRANCKEN, M.A.E. & FEASTER, D. (1995). On the putative efficacy of the antidepressants in chronic, benign pain syndromes: an update. Pain Forum, 4, 237-247.
44. GRUBER, A.J., HUDSON, J.I. & POPE, H.G. JR (1996). The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. Psychiatric Clinics of North America, 19, 351-369.
45. HARBINSON, J., DENNEHY, F. & KEATING, D. (1997). Lamotrigine for pain with hyperalgesia. Irish Medical Journal, 90, 56.
46. HASEGAWA, A.E. & ZACNY, J.P. (1997). The influence of three L-type calcium channel blockers on morphine effects in healthy volunteers. Anesthesia Analgesia, 85, 633-638.
47. HEISKANEN, T. & KALSO, E. (1997). Controlled-release oxycodone and morphine in cancer related pain. Pain, 73, 37-45.
48. HENDLER, N., CIMINI, C., MA, T. & LONG, D. (1980). A comparison of cognitive impairment due to benzodiazepines and to narcotics. American Journal of Psychiatry, 137, 828-830.
49. HERRICK, I.A., GANAPATHY, S., KOMAR, W., et al. (1996). Postoperative cognitive impairment in the elderly. Choice of patient-controlled analgesia opioid. Anaesthesia, 51, 356-360.
50. HODOGLUGIL, U., GUNEY, H.Z., SAVRAN, B., et al. (1996). Temporal variation in the interaction between calcium channel blockers and morphine-induced analgesia. Chronobiology International, 13, 227-234.
51. HOLISTER, L.E., CONLEY, F.K., BRITT, R. & SHUER, L. (1981). Long-term use of diazepam. Journal of the American Medical Association, 246, 1568-1570.
52. HOUTCHENS, M.K., RICHERT, J.R., SAMI, A., et al. (1997). Open label gabapentin treatment for pain in multiple sclerosis. Multiple Sclerosis, 3, 250-253.
53. HUNTER, J.C., GOGAS, K.R., HEDLEY, L.R., et al. (1997). The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. European Journal of Pharmacology, 324, 153-160.
54. JARVIS, B. & COUKELL, A.J. (1998). Mexiletine. A review of its therapeutic use in painful diabetic neuropathy. Drugs, 56, 691-707.
55. JENSEN, R., BRINCK, T. & OLESEN, J. (1994). Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology, 44, 647-651.
56. JETT, M.F., MCGUIRK, J., WALIGORA, D., et al. (1997). The effects of mexiletine, desipramine and fluoxetine in rat models involving central sensitization. Pain, 69, 161-169.
57. JUN, J.H. & YAKSH, T.L. (1998). The effect of intrathecal gabapentin and 3-isobutyl gamma-aminobutyric acid on the hyperalgesia observed after thermal injury in the rat. Anesthesia Analgesia, 86, 348-354.
58. KAMEI, J., SAITOH, A. & KASUYA, Y. (1995). Involvement of delta 1-opioid receptors in the antinociceptive effects of mexiletine in mice. Neuroscience Letter, 196, 169-172.
59. KANIECKI, R.G. (1997). A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology, 54, 1141-1145.
60. KING, S.A. & STRAIN, J.J. (1990). Benzodiazepine use by chronic pain patients. Clinical Journal of Pain, 6, 143-147.
61. KINGERY, W.S. (1997). A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain, 73, 123-139.
62. LANG, E., HORD, A.H. & DENSON, D. (1996). Venlafaxine hydrochloride (Effexor) relieves thermal hyperalgesia in rats with an experimental mononeuropathy. Pain, 68, 1151-1155.
63. LEACH, M.J., LEES, G., & RIDDALL, D.R. (1995). Lamotrigine: mechanisms of action. In: G.F. GEBHART, D.L. HAMMOND & T.S. JENSEN (Eds), Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Treatment (Vol. 2, pp 861-869). Seattle, WA: IASP Press.
64. LEES, G. & LEACH, M.J. (1993). Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex. Brain Research, 612, 190-199.
65. LEWIS, T.A. & SOLOMON, G.D. (1996). Advances in cluster headache management. Cleveland Clinic Journal of Medicine, 63, 237-244.
66. LORENZO, R.J. (1989). Mechanisms of action of phenytoin. In R.H. LEVY, F.E. DREIFUSS & R.H. MATTSON (Eds), Antiepileptic drugs (3rd edn, pp 143-158). New York: Raven Press.
67. MAGNI, G. (1987). On the relationship between chronic pain and depression when there is no organic lesion. Pain, 31, 1-21.
68. MAGNI, G. (1991). The use of antidepressants in the treatment of chronic pain: a review of the current evidence. Drugs, 42, 730-748.
69. MARKLEY, H.G. (1991). Verapamil and migraine prophylaxis: mechanisms and efficacy. American Journal of Medicine, 90, 48S-53S.
70. MARSON, A.G., KADIR, Z.A., HUTTON, J.L., et al. (1997). The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia, 38, 859-880.
71. MATHEW, N.T., SAPER, J.R., SILBERSTEIN, S.D., RANKIN, L., MARKLEY, H.G., SOLOMON, S., RAPOPORT, A.M., SILBER, C.J., DEATON. R.L. (1995). Migraine prophylaxis with divalproex. Archives of Neurology, 52, 281-286.
72. MAX, M.B. (1994). Treatment of post-herpetic neuralgia: antidepressants. Annals of Neurology, 35, 850-853.
73. MAX, M., LYNCH, S., MUIR, J., SHOAF, S., SMOLLER, B. & DUBNER, R. (1992). Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine, 326, 1250-1256.
74. MAX, M.B., CULNANE, M., SCHAFER, S.C., GRACELY, R.H., WALTHER, D.J., SMOLLER, B., DUBNER, R. (1987). Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology, 37, 589-596.
75. MAX, M.B., SCHAFER, S.C., CULNANE, M., et al. (1988). Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology, 38, 1427-1432.
76. MAX, M.B., KISHORE-KUMAR, R., SCHAFER, S.C., MEISTER, B., GRACELY, R.H., SMOLLER, B. & DUBNER, R. (1991). Efficacy of desipramine in painful diabetic neuropathy: a placebo controlled trial. Pain, 45, 3-9.
77. MCNAIRY, S.I., MARUTA, T., IVNIK, R.J., SWANSON, D.W. & ILSTRUP, D.M. (1984). Prescription medication dependence and neuropsychological function. Pain, 18, 169-177.
78. MCQUAY, H., CARROLL, D., JADAD, A.R., et al. (1995). Anticonvulsant drugs for management of pain: a systematic review. British Medical Journal, 311, 1047-1052.
79. MCQUAY, H.J., TRAMER, M., NYE, B.A., et al. (1996). A systematic review of antidepressants in neuropathic pain, Pain, 68, 217-227.
80. MENDELSON, G. & MENDELSON, D. (1991). Legal aspects of the management of chronic pain. Medical Journal of Australia, 155, 640-643.
81. MERIKANGAS, K.R. & MERIKANGAS, J.R. (1995). Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression. Biological Psychiatry, 38, 603-610.
82. MICO, J.A., GIBERT-RAHOLA, J. & CASAS, J., et al. (1997). Implication of beta 1-and beta 2-adrenergic receptors in the antinociceptive effect of tricyclic antidepressants. European Neuropsychopharmacology, 7, 139-145.
83. MITSIKOSTAS, D.D., GATZONIS, S., THOMAS, A., et al. (1997). Buspirone vs amitriptyline in the treatment of chronic tension-type headache. Acta Neurologica Scandinavia, 96, 247-251.
84. MOOSA, R.S., MCFAYDEN, M.L., MILLER, R. & RUBIN, J. (1993). Carbamazepine and its metabolites in neuralgias: concentration-effect relations. European Journal of Clinical Pharmacology, 45, 297-301.
85. MOULIN, D.E., IEZZI, A., AMIREH, R., et al. (1996). Randomised trial of oral morphine for chronic non-cancer pain. Lancet, 347, 143-147.
86. NEBE, J., VANEGAS, H., NEUGEBAUER, V., et al. (1997). Omega-agatoxin IVA, a P-type calcium channel antagonist, reduces nociceptive processing in spinal cord neurons with input from the inflamed but not from the normal knee joint - an electrophysiological study in the rat in vivo. European Journal of Neuroscience, 9, 2193-2201.
87. NISHIYAMA, K. & SAKUTA, M. (1995). Mexiletine for painful alcoholic neuropathy. Internal Medicine, 34, 577-579.
88. OLLAT, H. & CESARO, P. (1995). Pharmacology of neuropathic pain. Clinical Neuropharmacology, 18, 391-404.
89. ONGHENA, P. & VAN HOUDENHOVE, B. (1992). Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain, 49, 205-219.
90. OSKARSSON, P., LJUNGGREN, J.G. & LlNS, P.E. (1997). Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. Diabetes Care, 20, 1594-1597.
91. PAUL, D. & HORNBY, P.J. (1995). Potentiation of intrathecal DAMGO antinociception, but not gastrointenstinal transit inhibition, by 5-hydroxytryptamine and norepinephrine uptake blockade. Life Science, 56, PL83-PL87.
92. PICK, C.G., PAUL, D., EISON, M.S., et al. (1992). Potentiation of opioid analgesia by the antidepressant nefazodone. European Journal of Pharmacology, 211, 375-381.
93. PINELLI, A., TRIVULZIO, S. & TOMASONI, L. (1997). Effects of carbamazepine treatment on pain threshold values and brain serotonin levels in rats. Pharmacology, 54, 113-117.
94. PLATTEN, H.P., SCHWEIZER, E., DILGER, K., et al. (1998). Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction. Clinical Pharmacology and Therapy, 63, 552-560.
95. PORTENOY, R.K. (1990). Chronic opioid therapy in non-malignant pain. Journal of Pain and Symptom Management, 5(Suppl. 1), S46-S62.
96. PORTENOY, R.K. & FOLEY, K.M. (1986). Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain, 25, 171-186.
97. PORTENOY, R.K. & FOLEY, K.M. (1987). Constipation in the cancer patient. Medical Clinics of North America, 71, 303-312.
98. PORTER, J. & JICK, H. (1980). Addiction rate in patients treated with narcotics. New England Journal of Medicine, 302, 123.
99. RANI, P.U., NAIDU, M.U., PRASAD, V.B., et al. (1996). An evaluation of antidepressants in rheumatic pain conditions. Anesthesia Analgesia, 83, 371-375.
100. RAPP, S.E., EGAN, K.J., ROSS, B.K., et al. (1996). A multidimensional comparison of morphine and hydromorphone patient-controlled analgesia. Anesthesia Analgesia, 82, 1043-1048.
101. RICHEIMER, S.H., BAJWA, Z.H., KAHRAMAN, S.S., et al. (1997). Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: a survey. Clinical Journal of Pain, 13, 324-329.
102. ROOSE, S.P., GLASSMAN, A.H. & SIRIS, S. (1981). Comparison of imipramine and nortriptyline-induced orthostatic hypotension: a meaningful difference. Journal of Clinical Psychopharmacology, 1, 316-319.
103. ROTHROCK, J.F. (1997). Clinical studies of valproate for migraine prophylaxis. Cephalalgia, 17, 81-83.
104. ROWBOTHAM, M., HARDEN, N., STACEY, B., BERNSTEIN, P. & MAGNUS-MILLER, L. (1998). For the Gabapentin Postherpetic Neuralgia Study Group. Gabapentin for the treatment of postherpetic neuralgia. A randomized controlled trial. Journal of the American Medical Association, 280, 1837-1842.
105. SAWYNOK, J. (1985). GABAergic mechanisms of analgesia: an update. Pharmacology, Biochemistry and Behavior, 26, 463-474.
106. SCHREIBER, S., BACKER, M.M., YANAI, J., et al. (1996). The antinociceptive effect of fluvoxamine. European Neuropsychopharmacology, 6, 281-284.
107. SCHUG, S.A., MERRY, A.F. & ACLAND, R.H. (1991). Treatment principles for the use of opioids in pain of nonmalignant origin. Drugs, 42, 228-239.
108. SEES, K.L. & CLARK, H.W. (1993). Opioid use in the treatment of chronic pain: assessment of addiction. Journal of Pain and Symptom Management, 8, 257-264.
109. SHIMOYAMA, N., SHIMOYAMA, M., DAVIS, A.M., et al. (1997). Spinal gabapentin is antinociceptive in the rat formalin test. Neuroscience Letter, 222, 65-67.
110. SIMPSON, R.K. JR, EDMONDSON, E.A., CONSTANT, C.F., et al. (1997). Transdermal fentanyl as treatment for chronic low back pain. Journal of Pain and Symptom Management, 14, 218-224.
111. SINDRUP, S.H., GRAM, L.F., BROSEN, K., ESHOJ, O. & MORGENSEN, E.F. (19). The SSRI paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain, 42, 135-144.
112. SLUKA, K.A. (1997). Blockade of calcium channels can prevent the onset of secondary hyperalgesia and allodynia induced by intradermal injection of capsaicin in rats. Pain, 71, 157-164.
113. STEIN, C., SCHAFER, M., CABOT, P.J., et al. (1997). Opioids and inflammation. In: D. BORSOOK (Ed.), Molecular neurobiology of pain, progress in pain research and management (Vol. 9, pp. 25-43). Seattle, WA: IASP Press.
114. SULLIVAN, M., TOSHIMA, M., LYNN, P. & ROY-BYRNE, P. (1993). Phenobarbital versus clonazepam for sedative-hypnotic taper in chronic pain patients. A pilot study. Annals of Clinical Psychiatry, 5, 123-128.
115. TANELIAN, D.L. & VICTORY, R.A. (1995). Sodium channel-blocking agents: their use in neuropathic pain conditions. Pain Forum, 4, 75-80.
116. TANIGUCHI, K., MIYAGAWA, A., MIZUTANI, A., et al. (1995). The effect of calcium channel antagonist administered by iontophoresis on the pain threshold. Acta Anaesthesiology Belgium, 46, 69-73.
117. TAYLOR, C.P., GEE, N.S., SU, T.-Z., et al. (1998). A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Research, 29, 233-249.
118. TOKUNAGA, A., SAIKA, M. & SENBA, E. (1998). 5-HT2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery. Pain, 76, 349-355.
119. TURK, D.C., BRODY, M.C. & OKIFUJI, E.A. (1994). Physicians' attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain. Pain, 59, 201-208.
120. VOLMINK, J., LANCASTER, T., GRAY, S., et al. (1996). Treatments for postherpetic neuralgia - a systematic review of randomized controlled trials. Family Practice, 13, 84-91.
121. VRETHEM, M., BOIVIE, J., ARNQVIST, H., et al. (1997). A comparison of amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clinical Journal of Pain, 13, 313-323.
122. WATSON, C.P., EVANS, R.J., WATT, V.R. & BIRKETT, N. (1988). Postherpetic neuralgia, 208 causes. Pain, 35, 289-298.
123. WEBB, J. & KAMALI, F. (1998). Analgesic effects of lamotrigine and phenytoin on cold-induced pain: a crossover placebo-controlled study in healthy volunteers. Pain, 76, 357-363.
124. WEIZMAN, R., PANKOVA, I.A., SCHREIBER, S., et al. (1997). Flunarizine analgesia is mediated by mu-opioid receptors. Physiology and Behavior, 62, 1193-1195.
125. WETZEL, C.H. & CONNELLY, J.F. (1997). Use of gabapentin in pain management. Annals of Pharmacotherapy, 31, 1082-1083.
126. WIKLUND, I., HALLING, K., RYDEN-BERGSTEN, T., et al. (1997). Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study. Blood Pressure, 6, 357-364.
127. XIAO, W.H. & BENNETT, G.J. (1995). Synthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats. Journal of Pharmacology and Experimental Therapies, 274, 666-672.
128. YOSSELSON-SUPERSTINE, S., LlPMAN, A.G. & SANDERS, S.H. (1985). Adjunctive antianxiety agents in the management of chronic pain. Israel Journal of Medical Science, 21, 113-117.
129. ZEHENDER, M., GEIBEL, A., TREESE, N., HOHNLOSER, S., MEINERTZ, T. & JUST, H. (1988). Prediction of efficacy and tolerance of oral mexiletine by intravenous lidocaine application. Clinical Pharmacology and Therapy, 44, 389-395.
130. ZIELGER, D.K. (1994). Opiate and opioid use in patients with refractory headache. Cephalalgia, 14, 5-10.